Evolutionary cancer-favoring engineered vaccinia virus for metastatic hepatocellular carcinoma.
about
Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations.Vaccinia Virus Shuffling: deVV5, a Novel Chimeric Poxvirus with Improved Oncolytic PotencySynergistic suppression effect on tumor growth of acute myeloid leukemia by combining cytarabine with an engineered oncolytic vaccinia virus
P2860
Evolutionary cancer-favoring engineered vaccinia virus for metastatic hepatocellular carcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Evolutionary cancer-favoring e ...... atic hepatocellular carcinoma.
@en
Evolutionary cancer-favoring e ...... atic hepatocellular carcinoma.
@nl
type
label
Evolutionary cancer-favoring e ...... atic hepatocellular carcinoma.
@en
Evolutionary cancer-favoring e ...... atic hepatocellular carcinoma.
@nl
prefLabel
Evolutionary cancer-favoring e ...... atic hepatocellular carcinoma.
@en
Evolutionary cancer-favoring e ...... atic hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Evolutionary cancer-favoring e ...... atic hepatocellular carcinoma.
@en
P2093
Dae Hwan Kang
So Young Yoo
Su-Nam Jeong
P2860
P304
71489-71499
P356
10.18632/ONCOTARGET.17288
P407
P577
2017-04-20T00:00:00Z